BEIJING, May 8 (China Economic Net) - The Award Ceremony of the China (Henan) & Pakistan (Balochistan) Drawing Contest for Middle School Students and the Sister School Contract Signing Ceremony, co-hosted by the People’s Government of Henan Province, the Government of Balochistan, Chinese Embassy in Pakistan and undertaken by China Overseas Ports Holding Company (COPHC), etc., was held online in Zhengzhou and Gwadar simultaneously on May 7.
The Award Ceremony of the China (Henan) & Pakistan (Balochistan) Drawing Contest for Middle School Students is held in Zhengzhou and Gwadar online on May 7.
The 70th anniversary of the establishment of China-Pakistan diplomatic ties is around the corner. Since the beginning of 2021, the drawing contest themed by “Pakistan in my heart” and “China in my heart” had started among students of the Affiliated Middle School of Henan Normal University, Zhengzhou No. 122 Middle School and Gwadar Faqeer Middle School. Nearly 20,000 Chin
Chinese language teachers in Pakistan help carry on friendship--China Economic Net
en.ce.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from en.ce.cn Daily Mail and Mail on Sunday newspapers.
Chinese language teachers in Pakistan help carry on friendship
pakistantelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pakistantelegraph.com Daily Mail and Mail on Sunday newspapers.
Share:
EdiGene, Inc., which develops genome editing technologies to accelerate drug discovery and develop novel therapeutics for a broad range of diseases, today announced the appointment of Bo Zhang, Ph.D., as Head of the US Subsidiary, and Kehua Fan, M.D., as Head of Business Development. Both will report to Dr. Dong Wei, CEO of EdiGene. Our company and R&D portfolio are entering into an exciting phase, as evidenced by the recent close of Series B financing and submission of the first gene editing product IND in China, said Dong Wei, Ph.D.，CEO of EdiGene, Translating cutting-edge gene editing technologies into innovative solutions for patients requires deep internal R&D expertise as well as strong external partnerships. We are delighted to have Dr. Zhang and Dr. Fan join us at this significant stage of growth. Their extensive experience and proven track record in advancing innovative therapies, in addition to strong leadership skills, will help us to strengthen our portfolio